In the Media Tag: Michio Kurosu

 Provectus Biopharmaceuticals Establishes Research Collaboration with University of Tennessee Health Science Center to Investigate Small Molecule Rose Bengal Disodium for Antibiotic Resistance

In the Media Icon

Provectus (OTCQB: PVCT) today announced that the Company has initiated a new sponsored research program with Michio Kurosu, PhD, Professor, Department of Pharmaceutical Sciences at the College of Pharmacy of the University of Tennessee Health Science Center (UTHSC) in Memphis, Tennessee to investigate rose bengal disodium (RBD) targeting of multi-drug resistant (MDR) bacteria. RBD is… Read More

Inaugural CORNET Awards Presented for Nine Research Initiatives

In the Media Icon

Nine research grants have been announced as the 2016 awardees for the inaugural University of Tennessee Health Science Center (UTHSC) Collaborative Research Network (CORNET) Awards. This year’s winners are: Isaac Donkor, PhD; Michio Kurosu, PhD; Ying Kong, PhD Bob Moore, PhD; Byron Jones, PhD; Megan Mulligan, PhD Detlef Heck, PhD; Francesca-Fang Liao, PhD; Anton Reiner,… Read More

UTHSC’s Michio Kurosu Receives $431,000 Grant from NIH

In the Media Icon

Michio Kurosu, PhD, an associate professor in the Department of Pharmaceutical Sciences in the College of Pharmacy at the University of Tennessee Health Science Center,  has received a grant totaling $431,000 from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.